Publication:
Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects
Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects
dc.contributor.author | Halliday, Glenda | en_US |
dc.contributor.author | Bigio, Eileen H | en_US |
dc.contributor.author | Cairns, Nigel J | en_US |
dc.contributor.author | Neumann, Manuela | en_US |
dc.contributor.author | Mackenzie, Ian R | en_US |
dc.contributor.author | Mann, David MA | en_US |
dc.date.accessioned | 2021-11-25T12:28:45Z | |
dc.date.available | 2021-11-25T12:28:45Z | |
dc.date.issued | 2012 | en_US |
dc.description.abstract | Frontotemporal lobar degeneration (FTLD) is clinically, pathologically and genetically heterogeneous. The prototypical clinical syndromes are behavioural variant frontotemporal dementia (bvFTD), a disorder of behaviour and executive impairments, progressive non-fluent aphasia (PNFA), a disorder of expressive language, and semantic dementia (SD), a disorder of conceptual knowledge [Neary et al 1998]. A proportion of patients with any of these syndromes of FTLD can develop the amyotrophic form of motor neurone disease (MND) [Neary et al 1990, Strong et al], further emphasising clinical heterogeneity within FTLD, and highlighting the long known association with, and suspected pathogenetic links between, FTLD and MND. | en_US |
dc.identifier.uri | http://hdl.handle.net/1959.4/53342 | |
dc.language | English | |
dc.language.iso | EN | en_US |
dc.rights | CC BY-NC-ND 3.0 | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/au/ | en_US |
dc.source | Legacy MARC | en_US |
dc.subject.other | progressive non-fluent aphasia | en_US |
dc.subject.other | Frontotemporal lobar degeneration | en_US |
dc.subject.other | behavioural variant | en_US |
dc.subject.other | semantic dementia | en_US |
dc.title | Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects | en_US |
dc.type | Journal Article | en |
dcterms.accessRights | open access | |
dspace.entity.type | Publication | en_US |
unsw.accessRights.uri | https://purl.org/coar/access_right/c_abf2 | |
unsw.description.publisherStatement | The final publication is available at Springer via http://dx.doi.org/10.1007/s00401-012-1030-4 | en_US |
unsw.identifier.doiPublisher | http://dx.doi.org/10.1007/s00401-012-1030-4 | en_US |
unsw.relation.FunderRefNo | GNT0630434 | en_US |
unsw.relation.faculty | Medicine & Health | |
unsw.relation.fundingScheme | Uncoupled Research Fellowship | en_US |
unsw.relation.ispartofissue | 3 | en_US |
unsw.relation.ispartofjournal | Acta Neuropathologica | en_US |
unsw.relation.ispartofpagefrompageto | 373-382 | en_US |
unsw.relation.ispartofvolume | 124 | en_US |
unsw.relation.originalPublicationAffiliation | Halliday, Glenda, Neuroscience Research Australia, Faculty of Medicine, UNSW | en_US |
unsw.relation.originalPublicationAffiliation | Bigio, Eileen H, 2Department of Pathology and Alzheimer Disease Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA | en_US |
unsw.relation.originalPublicationAffiliation | Cairns, Nigel J, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA | en_US |
unsw.relation.originalPublicationAffiliation | Neumann, Manuela, Department of Neuropathology, University of Tuebingen and German Center for Neurodegenerative Diseases Tuebingen, Tuebingen, Germany | en_US |
unsw.relation.originalPublicationAffiliation | Mackenzie, Ian R, Department of Pathology, University of British Columbia, Vancouver, Canada | en_US |
unsw.relation.originalPublicationAffiliation | Mann, David MA, School of Community Based Medicine, University of Manchester, Manchester, UK | en_US |
unsw.relation.school | Neuroscience Research Australia | * |
unsw.subject.fieldofresearchcode | 110903 Central Nervous System | en_US |
Files
Original bundle
1 - 1 of 1